StockMacro
Company, fund or insider

Help

Menu

Puma Biotechnology

$7.05 -3.0% in 6 monthsMarket cap $364.5M

PBYI on XNAS, Health Care, PUMA BIOTECHNOLOGY INC, job postings

Measures activity, not value. Not investment advice.

Shares fell 35% in a month while 12-month revenue grew 9.4% and net income fell 36%.

  • BadShort interest 8.3% of shares, 11.5 days to cover

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Industry
Pharmaceutical preparations (Health Care)
Employees
179
Website
pumabiotechnology.com
Listed
Nasdaq, US
Last results
5 Nov 2026
Next results
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $55.1M, net income $6.0M.
Quarter to 31 Dec 2021: revenue $55.4M, net income $4.2MQuarter to 31 Dec 2021: revenue $55.4M, net income $4.2MQuarter to 31 Mar 2022: revenue $45.7M, net income -$3.4MQuarter to 31 Mar 2022: revenue $45.7M, net income -$3.4MQuarter to 30 Jun 2022: revenue $59.5M, net income $9.4MQuarter to 30 Jun 2022: revenue $59.5M, net income $9.4MQuarter to 30 Sep 2022: revenue $57.1M, net income -$360KQuarter to 30 Sep 2022: revenue $57.1M, net income -$360KQuarter to 31 Dec 2022: revenue $65.7M, net income -$5.6MQuarter to 31 Dec 2022: revenue $65.7M, net income -$5.6MQuarter to 31 Mar 2023: revenue $52.8M, net income $1.4MQuarter to 31 Mar 2023: revenue $52.8M, net income $1.4MQuarter to 30 Jun 2023: revenue $54.6M, net income $2.1MQuarter to 30 Jun 2023: revenue $54.6M, net income $2.1MQuarter to 30 Sep 2023: revenue $56.1M, net income $5.8MQuarter to 30 Sep 2023: revenue $56.1M, net income $5.8MQuarter to 31 Dec 2023: revenue $72.2M, net income $12.3MQuarter to 31 Dec 2023: revenue $72.2M, net income $12.3MQuarter to 31 Mar 2024: revenue $43.8M, net income -$4.8MQuarter to 31 Mar 2024: revenue $43.8M, net income -$4.8MQuarter to 30 Jun 2024: revenue $47.1M, net income -$4.5MQuarter to 30 Jun 2024: revenue $47.1M, net income -$4.5MQuarter to 30 Sep 2024: revenue $80.5M, net income $20.3MQuarter to 30 Sep 2024: revenue $80.5M, net income $20.3MQuarter to 31 Dec 2024: revenue $59.1M, net income $19.3MQuarter to 31 Dec 2024: revenue $59.1M, net income $19.3MQuarter to 31 Mar 2025: revenue $46.0M, net income $3.0MQuarter to 31 Mar 2025: revenue $46.0M, net income $3.0MQuarter to 30 Jun 2025: revenue $52.4M, net income $5.9MQuarter to 30 Jun 2025: revenue $52.4M, net income $5.9MQuarter to 30 Sep 2025: revenue $54.5M, net income $8.8MQuarter to 30 Sep 2025: revenue $54.5M, net income $8.8MQuarter to 31 Dec 2025: revenue $75.5M, net income $13.4MQuarter to 31 Dec 2025: revenue $75.5M, net income $13.4MQuarter to 31 Mar 2026: revenue $44.8M, net income -$3.8MQuarter to 31 Mar 2026: revenue $44.8M, net income -$3.8MQuarter to 30 Jun 2026: revenue $56.5M, net income $8.2MQuarter to 30 Jun 2026: revenue $56.5M, net income $8.2MQuarter to 30 Sep 2026: revenue $55.1M, net income $6.0MQuarter to 30 Sep 2026: revenue $55.1M, net income $6.0M
31 Dec 2021RevenueNet incomeNet losstallest bar $80.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$55.1M$6.0M
30 Jun 2026$56.5M$8.2M
31 Mar 2026$44.8M-$3.8M
31 Dec 2025$75.5M$13.4M
30 Sep 2025$54.5M$8.8M
30 Jun 2025$52.4M$5.9M
31 Mar 2025$46.0M$3.0M
31 Dec 2024$59.1M$19.3M
30 Sep 2024$80.5M$20.3M
30 Jun 2024$47.1M-$4.5M
31 Mar 2024$43.8M-$4.8M
31 Dec 2023$72.2M$12.3M
30 Sep 2023$56.1M$5.8M
30 Jun 2023$54.6M$2.1M
31 Mar 2023$52.8M$1.4M
31 Dec 2022$65.7M-$5.6M
30 Sep 2022$57.1M-$360K
30 Jun 2022$59.5M$9.4M
31 Mar 2022$45.7M-$3.4M
31 Dec 2021$55.4M$4.2M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $231.8M $212.0M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +9.4% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $23.8M $37.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.46 $0.75
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 73.6% 76.9% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 11.3% 15.8% -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 10.3% 17.4% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 18.2% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $46.1M $42.9M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $108.6M $94.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $34.0M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – -$60.4M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $2.84
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 15.3 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.6 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 2.5 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Puma BiotechnologyPBYI (this company) $364.5M15.31.6+9.4%10.3%
Phathom PharmaceuticalsPHAT $378.8Mloss1.4+87%-30.2%
RezoluteRZLT $379.2Mloss–––
Opus GeneticsIRD $385.7Mloss48.7-46%–
Contineum TherapeuticsCTNM $340.8Mloss–––
Avalo TherapeuticsAVTX $390.9Mloss–––

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+1.1%

$55.1M vs $54.5M (quarter ended 30 Sep 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$734K

bought $0, sold $734K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-2.5%

156 13F filers vs 160

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

78%

40.3M shares held by 13F filers (30 Sep 2026) of 51.7M outstanding (2 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

8.3%

4.3M shares sold short (30 Oct 2026) of 51.7M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

11.5

4.3M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-5.3%

4.5M shares sold short in the report before, 4.3M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

41%

41% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 59%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

5

5 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

5 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $7.05 on 20 Nov 2026, +46% over 12 months (12-month range $4.84 to $11.26)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $2.1M in the last 12 months (the 12 months before: -$924K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 4 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $55.1M in the latest quarter, +1.1% on a year earlier.
Capital spending per quarter. Capital spending $0 in the latest quarter, -100% on a year earlier.
Institutional holders (13F filers). 156 13F filers reported holding it in the latest 13F quarter, +24% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
9 May 20258-K and other filingsDirector or officer change
9 May 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Nov 2024Sharp changeQuarterly revenue change: quarterly revenue change, 80.5M vs usual 55.3M (2024-09-30); 1.4x the same period a year earlier
24 Jun 20248-K and other filingsDirector or officer change
24 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Mar 2024Sharp changeShort interest spike: short interest spike, 4.1M vs usual 1.7M (2024-02-29); 3.6x the same period a year earlier
5 Mar 2024Sharp changeShort interest spike: short interest spike, 3.6M vs usual 1.6M (2024-02-15); 3.2x the same period a year earlier
13 Feb 2024Sharp changeShort interest spike: short interest spike, 3.2M vs usual 1.6M (2024-01-31); 3.1x the same period a year earlier
30 Jan 2024Sharp changeShort interest spike: short interest spike, 3.0M vs usual 1.6M (2024-01-12); 3.2x the same period a year earlier
16 Jan 2024Sharp changeShort interest spike: short interest spike, 2.9M vs usual 1.5M (2023-12-29); 3.3x the same period a year earlier
2 Jan 2024Sharp changeShort interest spike: short interest spike, 2.8M vs usual 1.4M (2023-12-15); 1.9x the same period a year earlier
2 Aug 20228-K and other filingsDirector or officer change
2 Aug 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Dec 20218-K and other filingsDirector or officer change
13 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$10K published
Month from 1 Jan 2022: -$124K published
Month from 1 Feb 2022: -$5K published
Month from 1 Mar 2022: -$76K published
Month from 1 Apr 2022: -$6K published
Month from 1 May 2022: -$4K published
Month from 1 Jun 2022: -$245K published
Month from 1 Jul 2022: -$102K published
Month from 1 Aug 2022: -$94K published
Month from 1 Sep 2022: -$5K published
Month from 1 Oct 2022: -$4K published
Month from 1 Nov 2022: -$4K published
Month from 1 Dec 2022: -$11K published
Month from 1 Jan 2023: -$217K published
Month from 1 Jun 2023: -$378K published
Month from 1 Jul 2023: -$338K published
Month from 1 Nov 2023: -$71K published
Month from 1 Jan 2024: -$388K published
Month from 1 Jun 2024: -$324K published
Month from 1 Jul 2024: -$233K published
Month from 1 Aug 2024: -$82K published
Month from 1 Jan 2025: -$196K published
Month from 1 Jun 2025: -$312K published
Month from 1 Jul 2025: -$319K published
Month from 1 Nov 2025: -$97K published
Month from 1 Jan 2026: -$322K published
Month from 1 Jun 2026: -$573K published
Month from 1 Jul 2026: -$511K published
Month from 1 Sep 2026: -$612K published
Month from 1 Nov 2026: -$121K published
H-1B/E-3 applications certified
Quarter from 1 Jul 2026: 4 published
Revenue per quarter
Quarter ended 31 Dec 2021: $55.4M, +5.3% on a year earlier; public on 4 Mar 2022
Quarter ended 31 Mar 2022: $45.7M, -53% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $59.5M, +11% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $57.1M, +23% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $65.7M, +19% on a year earlier; public on 3 Mar 2023
Quarter ended 31 Mar 2023: $52.8M, +15% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $54.6M, -8.3% on a year earlier; public on 4 Aug 2023
Quarter ended 30 Sep 2023: $56.1M, -1.7% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $72.2M, +9.9% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $43.8M, -17% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $47.1M, -14% on a year earlier; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $80.5M, +44% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $59.1M, -18% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $46.0M, +5.1% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $52.4M, +11% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $54.5M, -32% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $75.5M, +28% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $44.8M, -2.6% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $56.5M, +7.8% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $55.1M, +1.1% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2020: $23K; public on 4 Mar 2022
Quarter ended 31 Dec 2021: $0, -100% on a year earlier; public on 4 Mar 2022
Quarter ended 30 Sep 2022: $0; public on 3 Nov 2023
Quarter ended 31 Dec 2022: $0; public on 3 Mar 2023
Quarter ended 30 Sep 2023: $27K; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $45K; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $0; public on 9 May 2025
Quarter ended 30 Jun 2024: $20K; public on 2 Aug 2024
Quarter ended 30 Sep 2024: $20K, -26% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $16K, -64% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $61K; public on 9 May 2025
Quarter ended 30 Jun 2025: $20K, 0% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $26K, +30% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Mar 2026: $0, -100% on a year earlier; public on 8 May 2026
Quarter ended 30 Jun 2026: $0, -100% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $0, -100% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 98; public on 14 Feb 2022
31 Mar 2022 report: 101; public on 16 May 2022
30 Jun 2022 report: 84; public on 15 Aug 2022
30 Sep 2022 report: 79; public on 14 Nov 2022
31 Dec 2022 report: 83; public on 14 Feb 2023
31 Mar 2023 report: 74; public on 15 May 2023
30 Jun 2023 report: 64; public on 14 Aug 2023
30 Sep 2023 report: 65; public on 14 Nov 2023
31 Dec 2023 report: 79; public on 14 Feb 2024
31 Mar 2024 report: 90; public on 15 May 2024
30 Jun 2024 report: 94; public on 14 Aug 2024
30 Sep 2024 report: 96; public on 14 Nov 2024
31 Dec 2024 report: 108; public on 14 Feb 2025
31 Mar 2025 report: 112; public on 15 May 2025
30 Jun 2025 report: 118; public on 14 Aug 2025
30 Sep 2025 report: 126; public on 14 Nov 2025
31 Dec 2025 report: 146; public on 17 Feb 2026
31 Mar 2026 report: 152; public on 15 May 2026
30 Jun 2026 report: 160; public on 14 Aug 2026
30 Sep 2026 report: 156; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is research and development expense, quarter at $18.3M (30 Sep 2026), 1.3× its normal quarter; higher than 46% of its own history.
  • Insider net buying (open market): Insiders sold a net $2.1M in the last 12 months (the 12 months before: -$924K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 4 published in the last 12 months (none in the 12 months before).
  • Revenue per quarter: Revenue $55.1M in the latest quarter, +1.1% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 3 sales, $734K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
13 Nov 2026Michael Patrick MillerDirectorSell15,000$8.10$121KForm 4
16 Sep 2026Troy Edward WilsonDirectorSellplanned in advance (10b5-1)5,000$9.10$46KForm 4
16 Sep 2026Alessandra CesanoDirectorSellplanned in advance (10b5-1); after exercising options62,150$9.12$567KForm 4
8 Jul 2026Maximo F NouguesChief Financial OfficerSellplanned in advance (10b5-1)9,386$8.26$78KForm 4
8 Jul 2026Douglas M HuntSee RemarksSellplanned in advance (10b5-1)8,460$8.26$70KForm 4
8 Jul 2026Alan H AuerbachPresident and CEOSellplanned in advance (10b5-1)44,058$8.26$364KForm 4
15 Jun 2026Troy Edward WilsonDirectorSellplanned in advance (10b5-1)10,800$7.20$78KForm 4
15 Jun 2026Brian M StuglikDirectorSellplanned in advance (10b5-1)8,100$7.20$58KForm 4

156 institutions reported shares at the end of Q3 2026, 78% of the shares outstanding; 19 opened a position, 23 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.4.2M8.14%$41.8M+402K+11%
Acorn Capital Advisors, LLC4.1M7.99%$41.0MNo change
American Century Companies Inc2.7M5.31%$27.2M+423K+18%
Acadian Asset Management LLC2.1M4.03%+31K+1.5%
LSV Asset Management1.9M3.75%+323K+20%
Vanguard Portfolio Management LLC1.9M3.66%$18.8M+68K+3.7%
Renaissance Technologies LLC1.9M3.64%$18.7M+48K+2.6%
Vanguard Capital Management LLC1.8M3.58%$18.4M+13K+0.7%
Dimensional Fund Advisors LP1.6M3.01%$15.4M+38K+2.5%
Geode Capital Management, LLC1.3M2.58%$13.2M-6,650-0.5%

Company events

All 39 company events

Nothing in 12 months; the latest was filed 9 May 2025. Results releases and routine reports are left out.

FiledWhat happenedSource
9 May 2025Director or officer change8-K
24 Jun 2024Director or officer changeSame filing: shareholder vote results8-K
12 Dec 2022Signed a major agreementSame filing: sold shares privately8-K
22 Sep 2022Signed a major agreement8-K
2 Aug 2022Director or officer change8-K
14 Mar 2022Signed a major agreementSame filing: sold shares privately8-K
13 Dec 2021Director or officer change8-K
4 Nov 2021Signed a major agreement8-K

The 5 newest of 73 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 9 May 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 9 May 2025Filings record

    Director or officer change

  3. 12 Nov 2024Financials change

    reported revenue of $80.5M for the quarter ended 30 Sep 2024, 1.4× the same quarter last year.

    Same quarter last year: $56.1M; its normal quarter is $55.3M.

    See the evidence
    This period
    $80.5M (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    $55.3M
    Typical spread (median absolute deviation)
    $5.4M
    How far from its usual level
    +3.1
    Same quarter last year
    $56.1M
    History used
    2,557 days
    2022-09-30: $57.1M2022-12-31: $65.7M2023-03-31: $52.8M2023-06-30: $54.6M2023-09-30: $56.1M2023-12-31: $72.2M2024-03-31: $43.8M2024-06-30: $47.1M2024-09-30: $80.5M
    the quarter ended 30 Sep 20248 earlier quartersnormal: $55.3M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  4. 24 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 24 Jun 2024Filings record

    Director or officer change

  6. 12 Mar 2024Short interest and volume change

    had 4.1M shares sold short in the 29 Feb 2024 report, 3.6× the same report last year.

    Same report last year: 1.1M; its normal report is 1.7M.

    See the evidence
    This period
    4.1M (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    298K
    How far from its usual level
    +5.5
    Same report last year
    1.1M
    History used
    2,253 days
    2023-02-28: 1.1M2023-03-15: 1.2M2023-03-31: 1.3M2023-04-14: 1.3M2023-04-28: 1.4M2023-05-15: 1.4M2023-05-31: 1.4M2023-06-15: 1.4M2023-06-30: 1.6M2023-07-14: 1.7M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.7M2023-09-15: 1.7M2023-09-29: 1.7M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.9M2023-11-30: 2.0M2023-12-15: 2.8M2023-12-29: 2.9M2024-01-12: 3.0M2024-01-31: 3.2M2024-02-15: 3.6M2024-02-29: 4.1M
    the 29 Feb 2024 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 28 Feb 2024Short interest and volume change

    had 3.6M shares sold short in the 15 Feb 2024 report, 3.2× the same report last year.

    Same report last year: 1.1M; its normal report is 1.6M.

    See the evidence
    This period
    3.6M (the 15 Feb 2024 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    277K
    How far from its usual level
    +4.7
    Same report last year
    1.1M
    History used
    2,239 days
    2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.2M2023-03-31: 1.3M2023-04-14: 1.3M2023-04-28: 1.4M2023-05-15: 1.4M2023-05-31: 1.4M2023-06-15: 1.4M2023-06-30: 1.6M2023-07-14: 1.7M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.7M2023-09-15: 1.7M2023-09-29: 1.7M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.9M2023-11-30: 2.0M2023-12-15: 2.8M2023-12-29: 2.9M2024-01-12: 3.0M2024-01-31: 3.2M2024-02-15: 3.6M
    the 15 Feb 2024 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 10 Feb 2024Short interest and volume change

    had 3.2M shares sold short in the 31 Jan 2024 report, 3.1× the same report last year.

    Same report last year: 1.1M; its normal report is 1.6M.

    See the evidence
    This period
    3.2M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    259K
    How far from its usual level
    +4.1
    Same report last year
    1.1M
    History used
    2,224 days
    2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.2M2023-03-31: 1.3M2023-04-14: 1.3M2023-04-28: 1.4M2023-05-15: 1.4M2023-05-31: 1.4M2023-06-15: 1.4M2023-06-30: 1.6M2023-07-14: 1.7M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.7M2023-09-15: 1.7M2023-09-29: 1.7M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.9M2023-11-30: 2.0M2023-12-15: 2.8M2023-12-29: 2.9M2024-01-12: 3.0M2024-01-31: 3.2M
    the 31 Jan 2024 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 25 Jan 2024Short interest and volume change

    had 3.0M shares sold short in the 12 Jan 2024 report, 3.2× the same report last year.

    Same report last year: 936K; its normal report is 1.6M.

    See the evidence
    This period
    3.0M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    251K
    How far from its usual level
    +3.8
    Same report last year
    936K
    History used
    2,205 days
    2023-01-13: 936K2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.2M2023-03-31: 1.3M2023-04-14: 1.3M2023-04-28: 1.4M2023-05-15: 1.4M2023-05-31: 1.4M2023-06-15: 1.4M2023-06-30: 1.6M2023-07-14: 1.7M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.7M2023-09-15: 1.7M2023-09-29: 1.7M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.9M2023-11-30: 2.0M2023-12-15: 2.8M2023-12-29: 2.9M2024-01-12: 3.0M
    the 12 Jan 2024 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 11 Jan 2024Short interest and volume change

    had 2.9M shares sold short in the 29 Dec 2023 report, 3.3× the same report last year.

    Same report last year: 881K; its normal report is 1.5M.

    See the evidence
    This period
    2.9M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    222K
    How far from its usual level
    +4.2
    Same report last year
    881K
    History used
    2,191 days
    2022-12-30: 881K2023-01-13: 936K2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.2M2023-03-31: 1.3M2023-04-14: 1.3M2023-04-28: 1.4M2023-05-15: 1.4M2023-05-31: 1.4M2023-06-15: 1.4M2023-06-30: 1.6M2023-07-14: 1.7M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.7M2023-09-15: 1.7M2023-09-29: 1.7M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.9M2023-11-30: 2.0M2023-12-15: 2.8M2023-12-29: 2.9M
    the 29 Dec 2023 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 28 Dec 2023Short interest and volume change

    had 2.8M shares sold short in the 15 Dec 2023 report, 1.9× the same report last year.

    Same report last year: 1.4M; its normal report is 1.4M.

    See the evidence
    This period
    2.8M (the 15 Dec 2023 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    240K
    How far from its usual level
    +3.7
    Same report last year
    1.4M
    History used
    2,177 days
    2022-12-15: 1.4M2022-12-30: 881K2023-01-13: 936K2023-01-31: 1.1M2023-02-15: 1.1M2023-02-28: 1.1M2023-03-15: 1.2M2023-03-31: 1.3M2023-04-14: 1.3M2023-04-28: 1.4M2023-05-15: 1.4M2023-05-31: 1.4M2023-06-15: 1.4M2023-06-30: 1.6M2023-07-14: 1.7M2023-07-31: 1.6M2023-08-15: 1.6M2023-08-31: 1.7M2023-09-15: 1.7M2023-09-29: 1.7M2023-10-13: 1.7M2023-10-31: 1.7M2023-11-15: 1.9M2023-11-30: 2.0M2023-12-15: 2.8M
    the 15 Dec 2023 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 2 Aug 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 2 Aug 2022Filings record

    Director or officer change

  14. 13 Dec 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 13 Dec 2021Filings record

    Director or officer change

  16. 14 Jul 2021Filings record

    Director or officer change

  17. 16 Jun 2021Filings record

    Director or officer change

  18. 11 May 2021Financials change

    reported revenue of $98.2M for the quarter ended 31 Mar 2021, 1.9× the same quarter last year.

    Same quarter last year: $51.2M; its normal quarter is $55.1M.

    See the evidence
    This period
    $98.2M (the quarter ended 31 Mar 2021)
    Normal quarter (median of 8 earlier)
    $55.1M
    Typical spread (median absolute deviation)
    $4.2M
    How far from its usual level
    +7.0
    Same quarter last year
    $51.2M
    History used
    1,278 days
    2019-03-31: $99.1M2019-06-30: $53.9M2019-09-30: $56.4M2019-12-31: $62.9M2020-03-31: $51.2M2020-06-30: $70.6M2020-09-30: $50.8M2020-12-31: $52.6M2021-03-31: $98.2M
    the quarter ended 31 Mar 20218 earlier quartersnormal: $55.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  19. 29 Mar 2021Filings record

    Director or officer change

  20. 23 Feb 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  21. 23 Feb 2021Filings record

    Director or officer change

  22. 8 Jul 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 8 Jul 2020Filings record

    Director or officer change

  24. 13 Nov 2019Filings record

    Director or officer change

  25. 17 Oct 2019Filings record

    Director or officer change

  26. 10 Oct 2019Short interest and volume change

    had 8.2M shares sold short in the 30 Sep 2019 report, 1.8× the same report last year.

    Same report last year: 4.6M; its normal report is 4.7M.

    See the evidence
    This period
    8.2M (the 30 Sep 2019 report)
    Normal report (median of 24 earlier)
    4.7M
    Typical spread (median absolute deviation)
    531K
    How far from its usual level
    +4.4
    Same report last year
    4.6M
    History used
    640 days
    2018-09-28: 4.6M2018-10-15: 5.1M2018-10-31: 4.7M2018-11-15: 3.8M2018-11-30: 3.9M2018-12-14: 3.5M2018-12-31: 4.2M2019-01-15: 4.5M2019-01-31: 5.2M2019-02-15: 5.0M2019-02-28: 4.6M2019-03-15: 4.8M2019-03-29: 3.8M2019-04-15: 4.7M2019-04-30: 4.3M2019-05-15: 4.1M2019-05-31: 4.3M2019-06-14: 3.9M2019-06-28: 6.8M2019-07-15: 7.5M2019-07-31: 7.3M2019-08-15: 8.9M2019-08-30: 8.8M2019-09-13: 8.9M2019-09-30: 8.2M
    the 30 Sep 2019 report24 earlier reportsnormal: 4.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 8 Oct 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  28. 8 Oct 2019Filings record

    Director or officer change

  29. 25 Sep 2019Short interest and volume change

    had 8.9M shares sold short in the 13 Sep 2019 report, 2.2× the same report last year.

    Same report last year: 4.0M; its normal report is 4.6M.

    See the evidence
    This period
    8.9M (the 13 Sep 2019 report)
    Normal report (median of 24 earlier)
    4.6M
    Typical spread (median absolute deviation)
    531K
    How far from its usual level
    +5.5
    Same report last year
    4.0M
    History used
    623 days
    2018-09-14: 4.0M2018-09-28: 4.6M2018-10-15: 5.1M2018-10-31: 4.7M2018-11-15: 3.8M2018-11-30: 3.9M2018-12-14: 3.5M2018-12-31: 4.2M2019-01-15: 4.5M2019-01-31: 5.2M2019-02-15: 5.0M2019-02-28: 4.6M2019-03-15: 4.8M2019-03-29: 3.8M2019-04-15: 4.7M2019-04-30: 4.3M2019-05-15: 4.1M2019-05-31: 4.3M2019-06-14: 3.9M2019-06-28: 6.8M2019-07-15: 7.5M2019-07-31: 7.3M2019-08-15: 8.9M2019-08-30: 8.8M2019-09-13: 8.9M
    the 13 Sep 2019 report24 earlier reportsnormal: 4.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 12 Sep 2019Short interest and volume change

    had 8.8M shares sold short in the 30 Aug 2019 report, 2.4× the same report last year.

    Same report last year: 3.6M; its normal report is 4.6M.

    See the evidence
    This period
    8.8M (the 30 Aug 2019 report)
    Normal report (median of 24 earlier)
    4.6M
    Typical spread (median absolute deviation)
    522K
    How far from its usual level
    +5.5
    Same report last year
    3.6M
    History used
    609 days
    2018-08-31: 3.6M2018-09-14: 4.0M2018-09-28: 4.6M2018-10-15: 5.1M2018-10-31: 4.7M2018-11-15: 3.8M2018-11-30: 3.9M2018-12-14: 3.5M2018-12-31: 4.2M2019-01-15: 4.5M2019-01-31: 5.2M2019-02-15: 5.0M2019-02-28: 4.6M2019-03-15: 4.8M2019-03-29: 3.8M2019-04-15: 4.7M2019-04-30: 4.3M2019-05-15: 4.1M2019-05-31: 4.3M2019-06-14: 3.9M2019-06-28: 6.8M2019-07-15: 7.5M2019-07-31: 7.3M2019-08-15: 8.9M2019-08-30: 8.8M
    the 30 Aug 2019 report24 earlier reportsnormal: 4.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 27 Aug 2019Short interest and volume change

    had 8.9M shares sold short in the 15 Aug 2019 report, 2.0× the same report last year.

    Same report last year: 4.3M; its normal report is 4.4M.

    See the evidence
    This period
    8.9M (the 15 Aug 2019 report)
    Normal report (median of 24 earlier)
    4.4M
    Typical spread (median absolute deviation)
    441K
    How far from its usual level
    +6.8
    Same report last year
    4.3M
    History used
    594 days
    2018-08-15: 4.3M2018-08-31: 3.6M2018-09-14: 4.0M2018-09-28: 4.6M2018-10-15: 5.1M2018-10-31: 4.7M2018-11-15: 3.8M2018-11-30: 3.9M2018-12-14: 3.5M2018-12-31: 4.2M2019-01-15: 4.5M2019-01-31: 5.2M2019-02-15: 5.0M2019-02-28: 4.6M2019-03-15: 4.8M2019-03-29: 3.8M2019-04-15: 4.7M2019-04-30: 4.3M2019-05-15: 4.1M2019-05-31: 4.3M2019-06-14: 3.9M2019-06-28: 6.8M2019-07-15: 7.5M2019-07-31: 7.3M2019-08-15: 8.9M
    the 15 Aug 2019 report24 earlier reportsnormal: 4.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 10 Aug 2019Short interest and volume change

    had 7.3M shares sold short in the 31 Jul 2019 report, 1.6× the same report last year.

    Same report last year: 4.6M; its normal report is 4.4M.

    See the evidence
    This period
    7.3M (the 31 Jul 2019 report)
    Normal report (median of 24 earlier)
    4.4M
    Typical spread (median absolute deviation)
    379K
    How far from its usual level
    +5.2
    Same report last year
    4.6M
    History used
    579 days
    2018-07-31: 4.6M2018-08-15: 4.3M2018-08-31: 3.6M2018-09-14: 4.0M2018-09-28: 4.6M2018-10-15: 5.1M2018-10-31: 4.7M2018-11-15: 3.8M2018-11-30: 3.9M2018-12-14: 3.5M2018-12-31: 4.2M2019-01-15: 4.5M2019-01-31: 5.2M2019-02-15: 5.0M2019-02-28: 4.6M2019-03-15: 4.8M2019-03-29: 3.8M2019-04-15: 4.7M2019-04-30: 4.3M2019-05-15: 4.1M2019-05-31: 4.3M2019-06-14: 3.9M2019-06-28: 6.8M2019-07-15: 7.5M2019-07-31: 7.3M
    the 31 Jul 2019 report24 earlier reportsnormal: 4.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 25 Jul 2019Short interest and volume change

    had 7.5M shares sold short in the 15 Jul 2019 report, 1.6× the same report last year.

    Same report last year: 4.8M; its normal report is 4.4M.

    See the evidence
    This period
    7.5M (the 15 Jul 2019 report)
    Normal report (median of 24 earlier)
    4.4M
    Typical spread (median absolute deviation)
    374K
    How far from its usual level
    +5.6
    Same report last year
    4.8M
    History used
    563 days
    2018-07-13: 4.8M2018-07-31: 4.6M2018-08-15: 4.3M2018-08-31: 3.6M2018-09-14: 4.0M2018-09-28: 4.6M2018-10-15: 5.1M2018-10-31: 4.7M2018-11-15: 3.8M2018-11-30: 3.9M2018-12-14: 3.5M2018-12-31: 4.2M2019-01-15: 4.5M2019-01-31: 5.2M2019-02-15: 5.0M2019-02-28: 4.6M2019-03-15: 4.8M2019-03-29: 3.8M2019-04-15: 4.7M2019-04-30: 4.3M2019-05-15: 4.1M2019-05-31: 4.3M2019-06-14: 3.9M2019-06-28: 6.8M2019-07-15: 7.5M
    the 15 Jul 2019 report24 earlier reportsnormal: 4.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 11 Jul 2019Short interest and volume change

    had 6.8M shares sold short in the 28 Jun 2019 report, 1.5× the same report last year.

    Same report last year: 4.5M; its normal report is 4.4M.

    See the evidence
    This period
    6.8M (the 28 Jun 2019 report)
    Normal report (median of 24 earlier)
    4.4M
    Typical spread (median absolute deviation)
    344K
    How far from its usual level
    +4.7
    Same report last year
    4.5M
    History used
    546 days
    2018-06-29: 4.5M2018-07-13: 4.8M2018-07-31: 4.6M2018-08-15: 4.3M2018-08-31: 3.6M2018-09-14: 4.0M2018-09-28: 4.6M2018-10-15: 5.1M2018-10-31: 4.7M2018-11-15: 3.8M2018-11-30: 3.9M2018-12-14: 3.5M2018-12-31: 4.2M2019-01-15: 4.5M2019-01-31: 5.2M2019-02-15: 5.0M2019-02-28: 4.6M2019-03-15: 4.8M2019-03-29: 3.8M2019-04-15: 4.7M2019-04-30: 4.3M2019-05-15: 4.1M2019-05-31: 4.3M2019-06-14: 3.9M2019-06-28: 6.8M
    the 28 Jun 2019 report24 earlier reportsnormal: 4.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  35. 12 Feb 2019Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 12 Feb 2019Filings record

    Director or officer change

  37. 9 Nov 2018Filings record

    Director or officer change (dated 8 Nov 2018)

  38. 1 Mar 2018Filings record

    Report will be filed late

  39. 27 Feb 2018Filings record

    Director or officer change

  40. 2 Aug 2017Filings record

    Director or officer change

Showing the newest 40 of 46 entries; narrow the window or the kind of data to see older ones.

Not listed: 403 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001401667
Ticker
PBYI
Domain
pumabiotechnology.com
Employer name
Puma Biotechnology, Inc (1 unverified)
Fein
77-0683487 (1 unverified)
Hq location
CA|LOS ANGELES| (1 unverified)
Name
EX-21.1, ex_896263.htm, INNOVATIVE ACQUISITIONS CORP, PUMA BIOTECHNOLOGY INC
Uei
JLJDGN4NRBP3
Wikidata
Q28877490
Wikipedia
Puma Biotechnology
  • DOL H-1B labor condition applications and PERM certifications10 data points15 Jun 2026 to 22 Jun 2026
  • SEC Form 13F institutional holdings1 record, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)171 records29 Feb 2016 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1034 data points26 Apr 2007 to 2 Nov 2026
  • SEC Form 4 insider transactions254 records, 400 data points24 Jan 2017 to 13 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards21 data points17 Jan 2018 to 10 Jun 2020
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026